Alkali Metals share price & results
- Sept 2026
- Jun 2026
Hyderabad-based manufacturer of sodium-based and pyridine specialty fine chemicals, pharmaceutical intermediates and APIs, operating as an ISO-certified Export House.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 27.3 | +45.3% YoY | Quarterly, as filed | Quarter to Sept 2026 | Revenue from operations as filed. |
| Operating margin | 4.7 | +3.8 pts YoY | Operating profit / revenue | Quarter to Sept 2026 | For the quarter; a change is in percentage points. |
| Net profit | 0.58 | Quarterly, as filed | Quarter to Sept 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. | |
| Return on equity | 5.89 | +9.2 pts | Trailing twelve months | TTM to Sept 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | 2.69 | −2.7 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 13.73 | +13.6 pts | Trailing twelve months | TTM to Sept 2026 | Revenue change against the same period one year earlier. |
Price
Performance −14.1% 1Y
1Y: ₹88.45 on 24 Oct 2025 → ₹76. High ₹103.2 (22 Sept 2026), low ₹47.61 (30 Mar 2026).
- Previous close
- ₹77.63
- Market cap
- ₹95 Cr
- 52-week range
- ₹47.61 – ₹103.2
- One year
- −13.09%
- Price to earnings (TTM to Sept 2026)
- 37.04×
- Return on equity (TTM to Sept 2026)
- 5.89%
Overview
- Symbol
- NSE:ALKALI
- Sector
- Chemicals
- Industry
- Commodities
- Exchange
- NSE
- Currency
- INR
What Alkali Metals Limited does
Based on the company's own presentations, annual report and earnings calls.
Alkali Metals Limited manufactures organic and inorganic fine chemicals, pharmaceutical intermediates and active pharmaceutical ingredients (APIs), with a product range spanning Sodium Amide, Sodium Alkoxides, Sodium Hydride, Sodium Azide, Tetrazoles, Amino Pyridines, Pyridine Derivatives and Cyclic Compounds. It runs three manufacturing units in Telangana (Uppal, Hyderabad and Medchal district) and Andhra Pradesh (Visakhapatnam), and maintains an in-house R&D team focused on developing new products and processes. The company sells to both domestic and export markets and is recognized as an ISO 9001 & 14001 certified Export House.
- Manufacturing units
- 3 (Uppal-Hyderabad, Medchal district, Visakhapatnam)
- Employees
- 106
- Product range
- 11 chemical/API product lines (sodium derivatives, pyridine derivatives, cyclic compounds, APIs)
- Export / quality certification
- ISO 9001 & 14001 certified; recognized Export House
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
What the filings say
Net profit, year on year: +164% (quarter to sept 2026 against sept 2025).
| Line item | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 22 | 25 | 21 | 19 | 25 | 29 | 18 | 27 |
| Expenses | 24 | 22 | 19 | 19 | 25 | 23 | 18 | 26 |
| Operating profit | -2 | 3 | 2 | 0 | -0 | 6 | -0 | 1 |
| Operating margin | −8.7% | 12.8% | 7.5% | 1.0% | −1.0% | 21.2% | −1.9% | 4.7% |
| Other income | -1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Interest | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | -5 | 2 | 0 | -1 | -1 | 5 | -1 | 1 |
| Tax rate | 4.2% | −114.3% | 448.5% | 0.0% | 0.0% | 24.1% | 0.0% | 0.0% |
| Net profit | -5 | 4 | -1 | -1 | -1 | 4 | -1 | 1 |
| EPS (₹ per share) | -4.84 | 4.27 | -1.13 | -0.89 | -1.37 | 3.95 | -0.63 | 0.57 |
| Line item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 83 | 82 | 93 |
| Expenses | 75 | 83 | 85 |
| Operating profit | 8 | -1 | 8 |
| Other income | 1 | -1 | 1 |
| Interest | 3 | 2 | 2 |
| Depreciation | 5 | 4 | 3 |
| Profit before tax | 2 | -8 | 3 |
| Net profit | 1 | -6 | 1 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 | Sept 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 43 | 41 | 34 | 32 | 35 | 33 |
| Borrowings | 24 | 23 | 18 | 18 | 18 | 21 |
| Other liabilities | 25 | 31 | 28 | 23 | 30 | 31 |
| Total liabilities | 102 | 106 | 91 | 83 | 93 | 96 |
| Fixed assets | 49 | 47 | 41 | 40 | 38 | 37 |
| Capital work in progress | 1 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 51 | 58 | 50 | 44 | 54 | 59 |
| Total assets | 102 | 106 | 91 | 83 | 93 | 96 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 1 | 11 | 11 | 6 | 5 | 3 |
| Cash from investing | -4 | -3 | -3 | -2 | -1 | -0 |
| Cash from financing | 0 | -7 | -9 | -6 | -4 | -3 |
| Net cash flow | -2 | 2 | -1 | -1 | 0 | 0 |
| Free cash flow | -2 | 8 | 8 | 5 | 4 | 3 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 79 | 54 | 57 | 79 | 64 | 76 |
| Inventory days | 494 | 246 | 278 | 382 | 223 | 224 |
| Days payable | 319 | 165 | 180 | 281 | 161 | 204 |
| Cash conversion cycle | 254 | 135 | 154 | 180 | 126 | 96 |
| Working capital days | 49 | 26 | 21 | 32 | 0 | 20 |
| Return on capital employed | 4.1% | 11.1% | 8.9% | 6.0% | −4.7% | 8.7% |
| Dividend payout | −67.3% | 58.5% | 70.0% | 90.1% | −8.8% | 181.8% |
Ownership
Who owns it
Promoters hold 69.59% as of Jun 2026; institutions added 0.00 pts since Mar 2026.
- Promoters 69.59%
- Foreign institutions 0.00%
- Public 30.40%
Who is on the register
Named in the Jun 2026 filing
Every holder of Alkali Metals Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| 67.81% | unchanged | |
| 1.08% | unchanged | |
| 0.41% | unchanged | |
| 0.28% | unchanged | |
| 0.01% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Alkali Metals Limited
Free account: one company. Everything above stays public.
Write why you follow Alkali Metals Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Chemicals companies
Learn to analyse Alkali Metals Limited
Guides on how to read this kind of business and the numbers that matter.